Projecten per jaar
Persoonlijk profiel
Expertise
PhD student with a focus on cell-based cancer (immuno)therapy and targeted cancer imagig. Experienced in nanobody generation, protein expression and purification, (in vivo) molecular nuclear imaging, flow cytometry, radioactive labelings, surface plasmon resonance, cell culture, subcloning and cell-based assays.
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Heleen Hanssens actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 12 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Actief
-
FWOSB58: Ontwikkeling van een NanoCAR-T cel benadering voor de behandeling van multipel myeloom
Hanssens, H., Devoogdt, N., De Veirman, K. & Breckpot, K.
1/01/19 → 31/12/22
Project: Fundamenteel
-
Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality
Baudhuin, H., Puttemans, J., Hanssens, H., Vanwolleghem, P., Hernot, S., Raes, G., Xavier, C., Lahoutte, T. & Debie, P., mei 2021, In : Pharmaceuticals. 14, 5, 19 blz., 407.Onderzoeksoutput: Article
-
The antigen-binding moiety in the driver's seat of CARs
Hanssens, H., Meeus, F., De Veirman, K., Breckpot, K. & Devoogdt, N., 24 mei 2021, In : Medicinal Research Reviews.Onderzoeksoutput: Scientific review
Open Access -
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 apr 2020, In : Cancers. 12, 4, 1017.Onderzoeksoutput: Article
Open AccessBestand9 Citaten (Scopus)61 Downloads (Pure) -
Theranostics in immuno-oncology using nanobody derivatives
Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 25 okt 2019, In : Theranostics. 9, 25, blz. 7772-7791 20 blz., 10.7150/thno.34941.Onderzoeksoutput: Scientific review
Open AccessBestand28 Citaten (Scopus)254 Downloads (Pure)
Activiteiten
-
VUB Phd Day 2021
Heleen Hanssens (Chair)27 mei 2021Activiteit: Participating in or organizing a public lecture/debate
-
EHA-EBMT 3rd European CAR T-Cell Meeting
Heleen Hanssens (Participant)4 feb 2021 → 6 feb 2021Activiteit: Participation in conference
-
-
1st Bonn Nanobody Symposium
Heleen Hanssens (Participant)5 sep 2019 → 6 sep 2019Activiteit: Participation in conference
-
BCLAS Symposium
Heleen Hanssens (Participant)20 mei 2019 → 21 mei 2019Activiteit: Participation in conference
Scriptie
-
Assessment of antigen-binding domain parameters important for adequate CAR-T-cell activation: evaluating different SLAMF7-targeting nanobodies.
Auteur: Meeus, F., Hanssens, H., De Veirman, K. & Devoogdt, N., 19 jun 2020Begeleider: Hanssens, H. (Advisor)
Scriptie/masterproef: Master's Thesis
-
'Development of a NanoCAR approach for the treatment of multiple myeloma
Auteur: Devoogdt, N., Breckpot, K., De Veirman, K. & Hanssens, H., 2022Scriptie/masterproef: Doctoral Thesis
-
Generation and validation of nanobodies targeting brain tumors with aberrant expression of epidermal growth factor receptor and human epidermal growth factor receptor 2
Auteur: Hanssens, H., Devoogdt, N., Muyldermans, S. & Puttemans, J., 13 sep 2018Begeleider: Puttemans, J. (Advisor)
Scriptie/masterproef: Master's Thesis